EMOQUETTE Drug Patent Profile
Which patents cover Emoquette, and what generic alternatives are available?
Emoquette is a drug marketed by Ph Health and is included in one NDA.
The generic ingredient in EMOQUETTE is desogestrel; ethinyl estradiol. There is one drug master file entry for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the desogestrel; ethinyl estradiol profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Emoquette
A generic version of EMOQUETTE was approved as desogestrel; ethinyl estradiol by DURAMED PHARMS BARR on August 12th, 1999.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for EMOQUETTE?
- What are the global sales for EMOQUETTE?
- What is Average Wholesale Price for EMOQUETTE?
Summary for EMOQUETTE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 2 |
| Patent Applications: | 475 |
| Drug Prices: | Drug price information for EMOQUETTE |
| DailyMed Link: | EMOQUETTE at DailyMed |
US Patents and Regulatory Information for EMOQUETTE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ph Health | EMOQUETTE | desogestrel; ethinyl estradiol | TABLET;ORAL-28 | 076675-001 | Feb 25, 2011 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
